Glenmark Pharmaceuticals
GLENMARK.NS
$26.88
Share price
-1.22%
Change (1 day)
27.04%
Change (1 year)
Categories
Revenue for Glenmark Pharmaceuticals (GLENMARK.NS)
Revenue in 2024 (TTM): NZ$2.56 Billion
According to Glenmark Pharmaceuticals
's latest financial reports the company's current revenue (TTM 
) is NZ$2.60 Billion. an increase over the revenue in the year 2023 that were of NZ$2.28 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Glenmark Pharmaceuticals from 2012 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | NZ$2.72 B | 19.64% |
| 2023 | NZ$2.28 B | -1.55% |
| 2022 | NZ$2.31 B | -2.55% |
| 2021 | NZ$2.37 B | 19.53% |
| 2020 | NZ$1.98 B | -8.03% |
| 2019 | NZ$2.16 B | 6.27% |
| 2018 | NZ$2.03 B | 2.23% |
| 2017 | NZ$1.99 B | 5.92% |
| 2016 | NZ$1.88 B | 18.76% |
| 2015 | NZ$1.58 B | 17.5% |
| 2014 | NZ$1.34 B | 17.08% |
| 2013 | NZ$1.15 B | 6.75% |
| 2012 | NZ$1.07 B |